WALTHAM, Mass.--(BUSINESS WIRE)--OXiGENE, Inc. (NASDAQ: OXGN) (XSSE: OXGN), a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that President and CEO Richard Chin, M.D., will present a corporate overview and update at the BIO CEO and Investor Conference on Tuesday, February 12, at 10:15 a.m. EST (7:15 a.m. PST), in the Waldorf-Astoria hotel’s Norse Suite in New York City, NY.
